Complete test offer

No. ID Analyzed disease
5 7 Breast /ovarian cancer –genetic predisposition BRCA1 -5382insC.4153delA, C61G
8 10 Breast, ovarian , colorectal, prostate gland, renal carcinoma, thymus gland carcinoma- susceptibility to -CHEK2 ((1100delC, IVS2+1GA, I157T)
14 16 Colon, lung and ovarian carcinoma –genetic predisposition (3020insC allele)
15 17 Rak - genetyczna predyspozycja, badanie nosicielsta mutacji markerowej CHEK2 (1100delC, IVS2+1GA)
17 19 CHEK2 ( genetic predisposition I157T )
18 20 Breast/ovarian/prostate cancer – susceptibility to (NBS1 657del5)
19 21 Melanoma, lung, colon cancer – susceptibility to (CDKN2A (p16)
52 55 Polymorphism C5972T in the BRCA2 gene
53 56 Cyp1B1 –breast/ovarian cancer susceptibility to (C142G, G355T, G4326C)
150 157 Li-Fraumeni syndrome
151 158 Li-Fraumeni syndrome
152 159 Medullary thyroid carcinoma, MEN2A, MEN2B
153 160 Medullary thyroid carcinoma, MEN2A, MEN2B (exon 11 – common mutations or any other exon)
155 164 Colorectal adenomatous polyposis, autosomal recessive (MUTYH gene – selected fragment)
156 165 Breast, ovarian cancer – genetic predisposition, BRCA1 gene mutation carrier test (3819del5)
195 211 Breast cancer, genetic predisposition - panel II (supplementary multi-gene test)
196 212 Breast cancer, genetic predisposition - panel I (multi-gene test)
197 213 Prostate cancer – genetic predisposition - panel (CHEK2 - 4 mutations, BRCA1, NBS1)
198 214 Colorectal cancer, genetic predisposition – panel (CHEK2, NOD2, P16)
199 215 Lung cancer – genetic predisposition - panel (NOD2, P16, P53 - 1 mutation, CYP1B1)